On Mar 14, 2022 Medilink Therapeutics closed a Series B round and raised $70,000,000 from Highlight Capital, Legend Capital, Loyal Valley Capital, LYFE Capital, Qiming Venture Partners, featuring lead investors LYFE Capital, Qiming Venture Partners.
About the company: Medilink Therapeutics is located at China, Asia.
“”
Company website: http://www.—